Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Vanda Pharmaceuticals Inc revealed its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0
In a filing, Vanda Pharmaceuticals Inc revealed its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $47600.0
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) does about 670.95K shares in volume on a normal day but saw 493956 shares change hands
